Clinical Trial Update: Efficacy and Safety of Ad5FGF-4 for Myocardial Ischemia in Patients With Stable Angina Due to Coronary Artery Disease [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Ad5FGF-4 for myocardial ischemia in patients with stable angina due to coronary artery disease was terminated. Final efficacy and safet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stable Angina Pectoris

Drugs mentioned

• Ad5FGF-4 (adenovirus type 5 fibroblast growth factor-4 gene therapy)

Snippet

Sponsor: Cardium Therapeutics | Conditions: Angina, Stable | Phase 3 | Status: TERMINATED